SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

63.66

163771.55

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.49

Back

divis laboratories ltd

Divi's Laboratories consolidated net profit declines 1.02% in the December 2025 quarter

Feb 11,2026

Net profit of Divi's Laboratories declined 1.02% to Rs 583.00 crore in the quarter ended December 2025 as against Rs 589.00 crore during the previous quarter ended December 2024. Sales rose 12.29% to Rs 2604.00 crore in the quarter ended December 2025 as against Rs 2319.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2604.00	2319.00	12
OPM %	34.18	32.04	-
PBDT	972.00	825.00	18
PBT	854.00	726.00	18
NP	583.00	589.00	-1

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)